0
0 (0%)
Sio Gene Therapies Inc. [AXGT]
Source:
Company Overview
Sio Gene Therapies Inc is a clinical-stage company focused on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | 877-746-4891 |
| Industry | manufacturing |
| CEO | David Nassif |
| Website | siogtx.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | |
| Net Income | $-4 |
| Net Cash | $0 |
Profit Ratios
| Gross Margin | |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -6.6% |
| Profit as % of Stockholder Equity | -8.9% |
Management Effectiveness
| Return on Equity | -8.9% |
| Return on Assets | -8.5% |
| Turnover Ratio | |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $47.3 |
| Total Liabilities | $2.2 |
| Operating Cash Flow | $0 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $0 |
